4.3 Article

Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis

Lara K. Marquez et al.

Summary: This study evaluated the progress of HCV elimination among MSM living with HIV in Germany using a transmission model. The results showed that by expanding the use of direct-acting antivirals (DAAs), the WHO incidence target can be achieved, indicating the importance of scaling up DAA treatment.

PLOS ONE (2022)

Article Substance Abuse

Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada

Charlotte Laniece Delaunay et al.

Summary: The study found that HCV treatment uptake and outcomes have improved among HIV-HCV coinfected PWID in Canada, but they still face drug-related harms. Gaps exist in engagement in harm reduction programs and efforts are needed to enhance these measures to improve overall health outcomes for this population.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

Article Gastroenterology & Hepatology

Impact of COVID-19 on global HCV elimination efforts

Sarah Blach et al.

Summary: The study focused on the impact of COVID-19 on hepatitis elimination programs, finding that a 1-year delay in diagnosis and treatment could lead to an additional 44,800 liver cancers and 72,300 HCV-related deaths globally by 2030. It emphasizes the importance of prioritizing hepatitis programs as soon as it becomes safe to do so.

JOURNAL OF HEPATOLOGY (2021)

Article Infectious Diseases

Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montreal: results from three cross-sectional studies (2005,2009,2018)

Charlotte Laniece Delaunay et al.

Summary: HCV seroprevalence among Montreal MSM remained stable between 2005 and 2018, with diverging trends between age groups. Lifetime injection drug use was found to be the strongest predictor of HCV seropositivity, and there was no association between HCV seroprevalence and sexual risk factors studied. Understanding the intersection of injection drug use contexts, practices, and populations is crucial for preventing HCV transmission among MSM.

SEXUALLY TRANSMITTED INFECTIONS (2021)

Article Substance Abuse

Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?

Charlotte Laniece Delaunay et al.

Summary: This study investigated the post-elimination transmission dynamics of HCV and HIV among PWID and found that maintaining elimination targets would require less effort than achieving them initially. Different scenarios of scaling down interventions were assessed, with high-coverage harm reduction interventions playing a key role in mitigating HCV resurgence.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Article Medicine, General & Internal

Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire

Andrew Blake et al.

Summary: This decision analytical model evaluates potential improvements in the hepatitis C virus (HCV) care cascade among people who inject drugs (PWID), focusing on improved testing, treatment uptake, and access to harm reduction. Findings from the study suggest that improvements in testing, treatment, and access to harm reduction were all associated with reductions in HCV prevalence and mortality among PWID. Improvements in testing and treatment were projected to achieve HCV prevalence of less than 2% by 2030.

JAMA NETWORK OPEN (2021)

Article Gastroenterology & Hepatology

Potential interventions to support HCV treatment uptake among HIV co-infected people in Canada: Perceptions of patients and health care providers

David Ortiz-Paredes et al.

Summary: The study explored the perspectives of people living with HIV and HCV co-infection and healthcare providers on interventions to support HCV treatment initiation. Patient and provider participants identified multidisciplinary clinics, HCV awareness campaigns and patient education, nurse- or pharmacist-led care, peer involvement, and more prepared health professionals as effective interventions. These proposed interventions aim to shift towards community-based care, emphasize the importance of education and structural changes, and potentially yield broader benefits for HIV-HCV co-infected individuals.

CANADIAN LIVER JOURNAL (2021)

Article Public, Environmental & Occupational Health

Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada

Brendan Jacka et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2020)

Article Gastroenterology & Hepatology

The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study

Adam Trickey et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Immunology

Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?

Natasha K. Martin et al.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2018)

Article Public, Environmental & Occupational Health

Quantifying potentially infectious sharing patterns among people who inject drugs in Baltimore, USA

M. K. Smith et al.

EPIDEMIOLOGY AND INFECTION (2018)

Review Gastroenterology & Hepatology

Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

Behzad Hajarizadeh et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Medicine, General & Internal

Hepatitis C virus infection

Michael P. Manns et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Medicine, General & Internal

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

Lucy Platt et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Psychology, Clinical

Impact of length of injecting career on HIV incidence among people who inject drugs

Jacqueline Montain et al.

ADDICTIVE BEHAVIORS (2016)

Article Pharmacology & Pharmacy

The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future

Alice Tseng et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)

Article Medicine, General & Internal

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1 A Randomized Trial

Mark S. Sulkowski et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Substance Abuse

The cost-effectiveness of harm reduction

David P. Wilson et al.

INTERNATIONAL JOURNAL OF DRUG POLICY (2015)

Review Pharmacology & Pharmacy

Evolution of HIV treatment guidelines in high- and low-income countries: Converging recommendations

Eugene T. Richardson et al.

ANTIVIRAL RESEARCH (2014)

Article Public, Environmental & Occupational Health

Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis

Esther J. Aspinall et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)

Article Gastroenterology & Hepatology

Natural history of hepatitis C

Rachel H. Westbrook et al.

JOURNAL OF HEPATOLOGY (2014)

Review Public, Environmental & Occupational Health

Mortality among people who inject drugs: a systematic review and meta-analysis

Bradley M. Mathers et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2013)

Article Medicine, General & Internal

Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis

Georgie J. MacArthur et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Editorial Material Medicine, General & Internal

Treatment as prevention-a double hat-trick

Julio S. G. Montaner

LANCET (2011)

Editorial Material Public, Environmental & Occupational Health

Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study

Marina B. Klein et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)

Article Psychology, Clinical

A Meta-Analysis of Retention in Methadone Maintenance by Dose and Dosing Strategy

Yan-ping Bao et al.

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2009)

Article Medicine, General & Internal

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

FJ Torriani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)